EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

Clinical characteristics, anti-SARS-CoV-2 IgG titers, and inflammatory markers in individuals with post-COVID-19 condition in Kenya: a cross-sectional study

Martin Theuri, Eric M Ndombi, Peris Thamaini, James Opiyo Ogutu iD, Lister Onsongo, June K Madete, Victor Ofula, Samuel Gitau, Gladys Mwangi, Paul Okemo

PeerJ · 2024

DOI: 10.7717/peerj.17723 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift PeerJ, 2024. Verfasst von Martin Theuri und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Science, Kenyatta University, Nairobi, Kenya. Hauptthemen laut MEDLINE: COVID-19, Immunoglobulin G, SARS-CoV-2, Interleukin-6. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation (NRF) South Africa.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Post-coronavirus disease 2019 (post-COVID-19) is associated with considerable morbidity and reduced quality of life. However, studies characterizing the post-COVID-19 condition in Kenya are limited. This study aimed to determine the prevalence of post-COVID-19 condition and determine the clinical characteristics, anti-SARS-CoV-2 IgG titers, and concentrations of inflammatory markers of individuals with post-COVID-19 condition in Kenya.

Methods

This descriptive cross-sectional study was conducted at the Kenyatta University Health Unit, Kenya. Demographic and clinical data were collected using a questionnaire. The serum levels of anti-SARS-CoV-2 antibodies, interleukin 6 (IL-6), and C-reactive protein (CRP) were quantified by enzyme-linked immunosorbent assays. Independent samples t-test was used to compare the anti-SARS-CoV-2 IgG, IL-6, and CRP levels between the participants with and without post-COVID-19 symptoms. The case definition for post-COVID-19 condition was persistence of acute COVID-19 symptoms or emergence of new symptoms 3 months after COVID-19 diagnosis, symptoms lasting for ≥2 months, and absence of any other etiological basis to explain the symptoms.

Results

A total of 189 volunteers were recruited in this study (median age: 21 years, range: 18–71 years; male, 49.2%). Forty participants reported having had at least one COVID-19 positive diagnosis in the past, of which 12 (30%) complained of post-COVID-19 symptoms. Significant differences in the number and duration of symptoms were observed between the individuals with and without post-COVID-19 symptoms ( t -statistic = 2.87, p = 0.01; t -statistic = 2.39, p = 0.02, respectively). However, no significant differences in serum levels of anti-SARS-CoV-2 IgG, IL-6, and CRP were observed between the two groups ( P = 0.08, 0.9, and 0.28, respectively).

Conclusion

These findings suggest that post-COVID-19 condition is a health concern even for a relatively young population in Kenya and globally. This condition requires more attention and well-designed studies to better define it and identify clinical chemistry markers that can be used for its diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Immunoglobulin GSARS-CoV-2Interleukin-6Antibodies, ViralC-Reactive ProteinBiomarkersHumansKenyaMaleCross-Sectional StudiesFemaleAdultMiddle AgedYoung AdultAgedAdolescent

Stichwörter der Autor:innen

Anti-SARS-CoV-2 IgGC-reactive proteinCOVID-19Clinical characteristicsInflammatory markersPost-COVID-19

Substanzen

Immunoglobulin GInterleukin-6Antibodies, ViralC-Reactive ProteinBiomarkers

Autor:innen und Institutionen

  • Department of Medical Laboratory Science, Kenyatta University, Nairobi, Kenya.
  • Department of Medical Microbiology and Parasitology, Kenyatta University, Nairobi, Kenya.
  • Department of Human Pathology, Kenyatta University, Nairobi, Kenya.
  • Department of Community and Reproductive Health Nursing, Kenyatta University, Nairobi, Kenya.
  • Department of Electrical and Electronic Engineering, Kenyatta University, Nairobi, Kenya.
  • Centre for Virus Research, kenya Medical Research Institute, Nairobi, Kenya.

ORCID-Profile: James Opiyo Ogutu

Förderung

  • National Research Foundation (NRF) South Africa

Zitieren

APA

Theuri, M., Ndombi, E. M., Thamaini, P., Ogutu, J. O., Onsongo, L., Madete, J. K., Ofula, V., Gitau, S., Mwangi, G., & Okemo, P. (2024). Clinical characteristics, anti-SARS-CoV-2 IgG titers, and inflammatory markers in individuals with post-COVID-19 condition in Kenya: a cross-sectional study. PeerJ. https://doi.org/10.7717/peerj.17723

Vancouver

Theuri M, Ndombi EM, Thamaini P, Ogutu JO, Onsongo L, Madete JK, et al. Clinical characteristics, anti-SARS-CoV-2 IgG titers, and inflammatory markers in individuals with post-COVID-19 condition in Kenya: a cross-sectional study. PeerJ. 2024. doi:10.7717/peerj.17723

BibTeX
@article{Theuri2024,
  author = {Theuri, Martin and Ndombi, Eric M and Thamaini, Peris and Ogutu, James Opiyo and Onsongo, Lister and Madete, June K and Ofula, Victor and Gitau, Samuel and Mwangi, Gladys and Okemo, Paul},
  title = {Clinical characteristics, anti-SARS-CoV-2 IgG titers, and inflammatory markers in individuals with post-COVID-19 condition in Kenya: a cross-sectional study},
  journal = {PeerJ},
  year = {2024},
  doi = {10.7717/peerj.17723}
}
Kostenlos starten →